Table of Contents
Executive Summary — 5
SWOT
Analysis — 6
Jordan Pharmaceuticals And Healthcare
Industry SWOT — 6
Jordan Political
SWOT — 7
Jordan Economic SWOT — 7
Jordan Business Environment Industry SWOT — 8
Pharmaceutical Business Environment Ratings — 9
Table:
Middle East And Africa (MEA) – Regional Pharmaceutical Business
Environment Ratings for Q409 — 9
Limits To Potential
Returns — 10
Risks To Realisation Of
Returns — 10
Market Summary — 11
Regulatory Regime — 13
Intellectual Property
Regime — 14
Recent IP
Developments — 14
Counterfeit
Pharmaceuticals — 15
Public Sector Procurement of
Medicines — 15
Pricing And Reimbursement
Issues — 16
Recent Pricing And Reimbursement
Developments — 16
International
Collaboration — 17
Recent International Collaboration
Developments — 18
Industry
Developments — 19
Epidemiology — 19
Healthcare Sector — 20
Health Insurance
Developments — 21
Recent Healthcare Sector
Developments — 22
Medical Tourism — 22
Domestic Pharmaceuticals Sector — 24
Recent Domestic
Company Activities — 25
Foreign
Companies — 27
Retail Pharmacy
Sector — 28
Research And Development
Sector — 28
Clinical Trials — 29
Medical Devices — 30
Industry Forecast
Scenario — 32
Overall Market
Forecasts — 32
Table: Jordan – Drug Market
Expenditure Indicators, Historical Data and Forecasts — 33
Key Growth Factors – Industry — 34
Table: Jordan
– Healthcare Expenditure Indicators, Historical Data and
Forecasts — 35
Macroeconomic
Forecast — 36
Table: Jordan – Economic Activity,
2006-2013 — 39
Prescription Drug Market
Forecast — 40
Table: Jordan – Prescription Market
Indicators, Historical Data and Forecasts (JODmn unless otherwise
stated) — 41
Patented Product Market
Forecast — 42
Table: Jordan – Patented Product
Market Indicators, Historical Data and Forecasts — 42
Generic Drug Market Forecast — 43
Table: Jordan –
Generics Market Indicators, Historical Data and
Forecasts — 43
OTC Drug Market
Forecast — 44
Table: Jordan – OTC Market Indicators,
Historical Data and Forecasts (JODmn unless otherwise
stated) — 45
Medical Device Market
Forecast — 46
Table: Jordan – Medical Device Market
Indicators, Historical Data and Forecasts — 46
Pharmaceutical Trade Forecast — 47
Table: Jordan –
Pharmaceutical Trade Indicators, Historical Data and Forecasts
(US$mn) — 49
Other Healthcare Data
Forecasts — 50
Table: Jordan - Other Healthcare
Indicators, Historical Data and Forecasts — 50
Key Risks
To BMI’s Forecasts — 51
Competitive
Landscape — 52
Company Monitor — 53
Multinational Companies — 53
Novartis — 53
Sanofi-Aventis — 54
Pfizer — 55
GlaxoSmithKline — 56
Merck
& Co — 57
Indigenous
Manufacturers — 58
Pharma International
Company — 58
Arab Pharmaceutical Manufacturers
(APM) — 59
Dar Al Dawa (DAD) — 61
Hikma Pharmaceuticals — 64
Jordanian Pharmaceutical
Manufacturing (JPM) — 68
United Pharmaceutical
Manufacturers — 70
Country Snapshot: Jordan Demographic
Data — 71
Section 1: Population — 71
Table: Demographic Indicators, 2005-2030 — 71
Table:
Rural/Urban Breakdown, 2005-2030 — 72
Section 2: Education
And Healthcare — 72
Table: Education,
2002-2005 — 72
Table: Vital Statistics,
2005-2030 — 72
Section 3: Labour Market And Spending
Power — 73
Table: Consumer Expenditure,
2000-2012 — 73
Table: Average Annual Manufacturing Wages,
2000-2012 — 73
BMI Forecast
Modelling — 74
How We Generate Our Pharmaceutical Industry
Forecasts — 74
Pharmaceutical Business Environment Ratings
Methodology — 75
Ratings Overview — 75
Table: Pharmaceutical Business Environment Indicators — 76
Weighting — 77
Table: Weighting Of
Components — 77
Sources — 77
| 
View Cart
